Gilder Gagnon Howe & Co’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.81M Sell
150,549
-51,663
-26% -$2.15M 0.07% 141
2025
Q4
$9.39M Sell
202,212
-3,095
-2% -$149K 0.1% 118
2025
Q3
$10.1M Buy
205,307
+19,458
+10% +$1.02M 0.1% 117
2025
Q2
$9.62M Buy
+185,849
New +$7.51M 0.1% 114

Other funds holding HNGE

Gilder Gagnon Howe & Co's HNGE Position: Q1 2026 in Review

Gilder Gagnon Howe & Co reduced its Hinge Health (HNGE) stake by 26% in Q1 2026, selling an estimated $2.15M and leaving 150,549 shares worth $5.81M. The position accounts for 0.07% of the portfolio, ranked #141.

Gilder Gagnon Howe & Co first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.1M in Q3 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Gilder Gagnon Howe & Co held 150,549 shares of Hinge Health worth $5.81M as of Q1 2026.
  • Gilder Gagnon Howe & Co sold 51,663 Hinge Health shares in Q1 2026, an estimated $2.15M.
  • Hinge Health made up 0.07% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #141 holding.
  • Gilder Gagnon Howe & Co first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • Gilder Gagnon Howe & Co's Hinge Health position peaked at $10.1M in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.